Skip to content
TrustList
ABS Capital Partners logo
Venture capital firm

ABS Capital Partners

Growth equity investor in business software and technology-enabled services companies across the United States

ABS Capital Partners cover

About ABS Capital Partners

ABS Capital Partners is a growth equity firm that invests in B2B software and technology-enabled services companies. It has been building businesses for more than thirty years and has invested in about 130 companies through eight funds.

Services

  • Growth equity: investment in emerging growth companies with strong technology and data foundations.
  • Operational guidance: help with infrastructure, data strategy and modernising processes.
  • Growth frameworks: flexible playbooks aimed at raising efficiency and widening market reach.

Clients

Software and tech-enabled services businesses across the United States, with attention to founders in regions where private capital is harder to find. Portfolio names include ExecOnline, Cordial, GuidePoint Security and Apptopia.

Key facts

  • Experience: More than 30 years
  • Funds: Eight
  • Geography: United States

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

What the business tells TrustList

Founded
1996 (30 years) evidence sent

Ask TrustList to introduce you to ABS Capital Partners

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of ABS Capital Partners

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about ABS Capital Partners.

ABS Capital Partners alternatives

Similar listings buyers compare against this one.

New York venture capital firm making early and growth stage investments on the East Coast, mostly as co-investor

Life science investor putting money into young oncology and genetic disease drug developers

London-rooted, FCA-regulated firm investing in early-stage companies and advising family offices on wealth